High-risk Combinations of Additional Chromosomal Abnormalities in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia: JALSG Ph+ALL TKI-SCT Study-Reference-Cited by-同舟云学术

High-risk Combinations of Additional Chromosomal Abnormalities in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia: JALSG Ph+ALL TKI-SCT Study

Published:2023-06 Issue:6 Volume:7 Page:e899
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Nishiwaki Satoshi¹,Sugiura Isamu²,Fujisawa Shin³,Hatta Yoshihiro⁴,Atsuta Yoshiko⁵⁶,Doki Noriko⁷,Kurahashi Shingo²,Ueda Yasunori⁸,Dobashi Nobuaki⁹,Maeda Tomoya¹⁰,Taniguchi Yasuhiro¹¹,Tanaka Masatsugu¹²,Kako Shinichi¹³,Ichinohe Tatsuo¹⁴,Fukuda Takahiro¹⁵,Ohtake Shigeki¹⁶,Ishikawa Yuichi¹⁷,Kiyoi Hitoshi¹⁷,Matsumura Itaru¹¹,Miyazaki Yasushi¹⁸,

Affiliation:

1. Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan

2. Division of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan

3. Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan

4. Department of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan

5. Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan

6. Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan

7. Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan

8. Department of Hematology/Oncology, Kurashiki Central Hospital, Kurashiki, Japan

9. Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan

10. Department of Hemato-Oncology, Saitama Medical University International Medical Center, Saitama, Japan

11. Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osakasayama, Japan

12. Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan

13. Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan

14. Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan

15. Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan

16. Kanazawa University, Kanazawa, Japan

17. Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan

18. Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan

Publisher

Wiley

Subject

Hematology

Reference15 articles.

1. Poor outcomes associated with +der(22)t(9;22) and -9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitor.;Short;Am J Hematol,2017

2. A multicenter total therapy strategy for de novo adult Philadelphia chromosome positive acute lymphoblastic leukemia patients: final results of the GIMEMA LAL1509 protocol.;Chiaretti;Haematologica,2021

3. Adult Ph-positive acute lymphoblastic leukemia-current concepts in cytogenetic abnormalities and outcomes.;Shi;Am J Cancer Res,2020

4. High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group.;Yanada;J Clin Oncol,2006

5. Phase II study of imatinib-based chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia.;Fujisawa;Am J Hematol,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Center effect on allogeneic hematopoietic stem cell transplantation outcomes for B-cell acute lymphoblastic leukemia;Cytotherapy;2024-05

2. Utility of allogeneic stem cell transplantation for adult Ph+ALL with complete molecular remission;American Journal of Hematology;2024-02-05